Invention Application
- Patent Title: BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
-
Application No.: US17693527Application Date: 2022-03-14
-
Publication No.: US20220306588A1Publication Date: 2022-09-29
- Inventor: Eva-Maria TANZER , Kai SCHIEMANN , Markus KLEIN
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Priority: EP17187101.5 20170821
- Main IPC: C07D235/30
- IPC: C07D235/30 ; A61P35/04 ; C07D401/12 ; C07D403/04 ; C07D403/10 ; C07D403/12 ; C07D405/04 ; C07D405/14 ; C07D413/04 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D471/10 ; C07D491/048 ; C07D491/052 ; C07D491/107 ; C07D491/113 ; C07D498/10
Abstract:
The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
Public/Granted literature
- US1737726A Engine timing gauge Public/Granted day:1929-12-03
Information query
